🇺🇸 Calcium and Magnesium in United States

87 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 87

Most-reported reactions

1. Nausea — 14 reports (16.09%)
2. Fatigue — 10 reports (11.49%)
3. Headache — 9 reports (10.34%)
4. Arthralgia — 8 reports (9.2%)
5. Diarrhoea — 8 reports (9.2%)
6. Dizziness — 8 reports (9.2%)
7. Dyspnoea — 8 reports (9.2%)
8. Pruritus — 8 reports (9.2%)
9. Pain — 7 reports (8.05%)
10. Tremor — 7 reports (8.05%)

Source database →

Frequently asked questions

Is Calcium and Magnesium approved in United States?

Calcium and Magnesium does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Calcium and Magnesium in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.